(Q35010167)

5 August 2017

title

Expression of beta-catenin in hepatocellular carcinoma (English)

1 reference

5 August 2017

Liem Thanh Tien

1

1 reference

5 August 2017

Masahiro Ito

2

1 reference

5 August 2017

Mikiko Nakao

3

1 reference

5 August 2017

Daisuke Niino

4

1 reference

5 August 2017

Meirmanov Serik

5

1 reference

5 August 2017

Masahiro Nakashima

6

1 reference

5 August 2017

Chun-Yang Wen

7

1 reference

5 August 2017

Hiroshi Yatsuhashi

8

1 reference

5 August 2017

Hiromi Ishibashi

9

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

World Journal of Gastroenterology

5 August 2017

published in

1 reference

5 August 2017

volume

11

1 reference

5 August 2017

issue

16

1 reference

5 August 2017

page(s)

2398-2401

1 reference

Stabilized beta-catenin promotes hepatocyte proliferation and inhibits TNFalpha-induced apoptosis.

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305624

Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305624

beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305624

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305624

Genetics of hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305624

Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305624

Genetic aspects of hepatocellular carcinogenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305624

Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305624

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305624

Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice

8 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I16.2398

Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I16.2398

Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I16.2398

Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I16.2398

Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I16.2398

Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I16.2398

Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305624

Genetic alterations and oncogenic pathways in hepatocellular carcinoma.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305624

Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features

26 October 2018

1 reference

12 December 2020

Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations

1 reference

12 December 2020

Beta-catenin expression in hepatocellular carcinoma: a possible participation of beta-catenin in the dedifferentiation process

1 reference

12 December 2020

Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival

1 reference

12 December 2020

Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I16.2398

1 reference

5 August 2017

1 reference

5 August 2017

1 reference